UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Applied Peritoneal Dialysis: Improving Patient Outcomes

1st Edition 2021, 2021

Volltextzugriff (PDF)

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia

Journal of the American Society of Nephrology, 2019-09, Vol.30 (9), p.1723-1733

2019

Volltextzugriff (PDF)

Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

Journal of the American Society of Nephrology, 2016-04, Vol.27 (4), p.1234-1244

2016

Volltextzugriff (PDF)

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

Kidney international, 2014-09, Vol.86 (3), p.638-647

2014

Volltextzugriff (PDF)

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Arthritis care & research (2010), 2012-06, Vol.64 (6), p.797-808

2012

Volltextzugriff (PDF)

Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial

Circulation. Heart failure, 2017-04, Vol.10 (4)

2017

Volltextzugriff (PDF)

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

BMC nephrology, 2023-01, Vol.24 (1), p.18-12, Article 18

2023

Volltextzugriff (PDF)

Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1192-1200

2013

Volltextzugriff (PDF)

One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis

Nephrology, dialysis, transplantation, 2017-11, Vol.32 (11), p.1918-1926

2017

Volltextzugriff (PDF)

Course of Hyperkalemia in Patients on Hemodialysis

International journal of nephrology, 2022-04, Vol.2022, p.6304571-11

2022

Volltextzugriff (PDF)

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

BMC nephrology, 2022-02, Vol.23 (1), p.59-59, Article 59

2022

Volltextzugriff (PDF)

Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review

Kidney medicine, 2020-03, Vol.2 (2), p.196-208

2020

Volltextzugriff (PDF)

Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation

PloS one, 2014-12, Vol.9 (12), p.e116530

2014

Volltextzugriff (PDF)

Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients

Clinical journal of the American Society of Nephrology, 2010-06, Vol.5 (6), p.1010-1014

2010

Volltextzugriff (PDF)

Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

Journal of primary care & community health, 2024-01, Vol.15, p.21501319241259905

2024

Volltextzugriff (PDF)

Long‐term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients

Hemodialysis international, 2018-10, Vol.22 (4), p.480-491

2018

Volltextzugriff (PDF)

Acute interstitial nephritis observed with three different triggering agents

Clinical case reports, 2022-03, Vol.10 (3), p.e05432-n/a

2022

Volltextzugriff (PDF)

A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis

Saudi journal of kidney diseases and transplantation, 2020-03, Vol.31 (2), p.508-514

2020

Volltextzugriff (PDF)

Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy

SAGE open medical case reports, 2019-08, Vol.7, p.2050313X19869764

2019

Volltextzugriff (PDF)

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease

Therapeutic Advances in Cardiovascular Disease, 2013-12, Vol.7 (6), p.322-342

Rastogi, Anjay

2013

Volltextzugriff (PDF)

Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan

Kidney medicine, 2020-01, Vol.2 (1), p.20-28

2020

Volltextzugriff (PDF)

Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Case reports in nephrology and dialysis, 2018-08, Vol.8 (2), p.171-177

2018

Volltextzugriff (PDF)

Technological Advances in Renal Replacement Therapy: Five Years and Beyond

Clinical journal of the American Society of Nephrology, 2009-12, Vol.4 (Supplement 1), p.S132-S136

2009

Volltextzugriff (PDF)

Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantation

Saudi journal of kidney diseases and transplantation, 2019-07, Vol.30 (4), p.989-994

2019

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Englisch
(204)

Erscheinungsjahr

n.n

Thema

Science & Technology
(92)
Life Sciences & Biomedicine
(91)
Humans
(65)
Urology & Nephrology
(60)
Female
(37)
Male
(35)
Middle Aged
(30)
Aged
(29)
Peritoneal Dialysis
(28)
Chronic Kidney Disease
(22)
Treatment Outcome
(22)
Risk Factors
(20)
Hemodialysis
(17)
Hypertension
(17)
Nephrology
(16)
Adult
(15)
Kidney Diseases
(14)
Blood Pressure
(12)
Renal Insufficiency, Chronic - Complications
(12)
Aged, 80 And Over
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Applied Peritoneal Dialysis: Improving Patient Outcomes

A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia

Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis

Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial

Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia

Multicenter Evaluation of the Clinical Outcomes of Daptomycin with and without Concomitant β-Lactams in Patients with Staphylococcus aureus Bacteremia and Mild to Moderate Renal Impairment

One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis

Course of Hyperkalemia in Patients on Hemodialysis

Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE

Advances in Autosomal Dominant Polycystic Kidney Disease: A Clinical Review

Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation

Reduction of Serum Hepcidin by Hemodialysis in Pediatric and Adult Patients

Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

Long‐term efficacy and safety of sucroferric oxyhydroxide in African American dialysis patients

Acute interstitial nephritis observed with three different triggering agents

A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis

Secondary membranous nephropathy in a patient with myasthenia gravis without thymic disease, and partial remission induced by adrenocorticotropic hormone therapy

Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease

Equivalent Efficacy and Decreased Rate of Overcorrection in Patients With Syndrome of Inappropriate Secretion of Antidiuretic Hormone Given Very Low-Dose Tolvaptan

Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency

Technological Advances in Renal Replacement Therapy: Five Years and Beyond

Everolimus worsening chronic proteinuria in patient with diabetic nephropathy post liver transplantation

Suchergebnisse filtern